<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2012-04-24 10:13:45Health Cytokines Hepatitis Interferon Ribavirin PEGylation Debiopharm Hepatitis C Acute pancreatitis Antivirals Pharmacology Medicine |
 | Debiopharm Group™ est un groupe international de quatre sociétés biopharmaceutiques basé en Suisse, actif dans les domaines du développement de médicaments, de la fabrication de médicaments exclusifs selon les BPDocID: 1r2k6 - View Document |
 | BIOTECH’S MOST RESPECTED NEWS SOURCE FOR MORE THAN 20 YEARS THURSDAY MARCH 15, 2012 VOLUME 23 , NO. 51DocID: 19ZND - View Document |
![Columns CHIMIA 2014, 68, Nr. 6 doi:[removed]chimia[removed]Chimia[removed]–451](https://www.pdfsearch.io/img/6622e3201dc9d9d2bf9370f3c7100881.jpg "Columns CHIMIA 2014, 68, Nr. 6 doi:[removed]chimia[removed]Chimia[removed]–451") | Columns CHIMIA 2014, 68, Nr. 6 doi:[removed]chimia[removed]Chimia[removed]–451DocID: QkF8 - View Document |
 | PDF DocumentDocID: Q6jk - View Document |
 | PRESS RELEASE Debiopharm Group™ and TCG Lifesciences Ltd. announce successful completion of first phase of research collaboration on discovery of novel antibiotics Lausanne, Switzerland and Kolkata, India – June 24 2DocID: PORs - View Document |